Get started

Cannabis

$LVGI Majority stake in Tulsa's first Cannabis Care Facility$LVGI Has been bringing in substantial revenues and most recently acquired a majority stake in Tulsa's first Cannabis Care Facility. The company expects further updates to be disseminated later this month, as the company moves forward with more developments in the CBD sector. Limitless Venture Group Inc., Acquires Majority Interest in Tulsa's First Medical Cannabis Care Facility Press Release | 01/07/2019 Tulsa, OK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Limitless Ventures Group Inc. (OTC PINK: LVGI) announced today it has signed an agreement and acquired the majority ownership stake in Tulsa, OK based Tulsa Higher Care Clinic Incorporated (THC²). CEO Joseph Francella states: "This is the ground floor opportunity we have been diligently searching for and LVGI will be forever transformed by this partnership. THC² gives LVGI immediate revenues and long-term unbelievable opportunities in the Cannabis Industry." LVGI has created a wholly owned subsidiary, Summit Harbor Holding Inc (SHHI), specifically for this acquisition, but more importantly, for all future Cannabis related acquisitions. Mr. Francella also states: "There will be many more acquisitions in this industry creating a fully integrated, synergistic and fully vertical company beginning this calendar year, 2019." THC² is a Medical Cannabis Care company operating in Tulsa, Oklahoma and will serve as the initial acquisition under SHHI. THC² was formed in June 2018, immediately after Medical Cannabis was approved in Oklahoma and it opened its first facility very shortly thereafter. THC² operates as the premier Medical Cannabis Care Facility in the state. The second facility is already under construction and is expected to be opened on or about February 1, 2019, with further statewide expansion plans in 2019. The mission of THC² is to evaluate, recommend and educate our patients on the benefits of Cannabis treatment, and set to the standard of Medical Cannabis Care in every community we provide our services.
OTC:LVGILong
by StockGuild
$ETII Third Major Leg Up on Increased Accum/Vol + News$ETII A major future player in the Pet CBD Sector is getting its ducks in a row before releasing updates on its future endeavors which should put the company ahead of direct competition in the sector. The company has had much success with its CBD edibles and Vape accessories and the new venture into a multi-billion dollar pet market should bring in substantial revenues in the near future. The chart itself has reflected massive accumulation in anticipation of its launch. I believe we should be hearing news on this venture very shortly followed by future updates on other streams of income the company has coming in.
OTC:ETIILong
by StockGuild
$CBDD Prepares for Massive Move with Rockstar CEO at the helm$CBDD or CBD Denver Inc. has a lot to look forward to. The company headed by CEO Nicholas Sprung who was in charge of building a multi-million dollar Ski supply company before taking the helm at $CBDD CBD Denver recently began a social networking website for fans of CBD and regular users who can get up to the minute information on the medical benefits and get connected to other CBD users. cbdsocialnetwork.com A huge tweet by the company posted January 9th is as follows: "As CBDSN expands, we'll need more dev hands on deck. Thus, I want to begin dialog w/ potential candidates. Any SEs, WEs, straight up coders, etc. interested in a position w/ CBDSN, please email contact@cbdsocialnetwork.com" I expect more news to be coming down the pipe very soon and for the PPS to reflect that initiative.
OTC:CBDDLong
by StockGuild
Dotcom bubble vs Canna bubble, Amazon vs Aurora, eye opening I went and compared the 2000 dotcom bubble burst to the 2018 cannabis bubble burst and i think there is a eye opening similarity. I see Aurora as a big player in the cannbiz but their delution on the shareholder will hurt the stock price even more. In my analysis there is a decline of another 50% to come and if you look at the numbers they forcast for their revenue Q2 2019 of 50 Mill. with a marketcap of 5 Bill. USD oh my, then you should absolutely keep a close eye on Aurora. In the future of pot I see them big but for now the investors will suffer some more pain and we might see the 2.50 again. I will acumulate on their way down and hold them for a long. Decline will probably keep going until mid 2019 Just my opinion so make your own resarch and like always May the markets be with you Follow me here and on Twitter @derfreietrader Thanks for your support
TSX:ACB
by derfreietrader
4
Significant delays for New Age Beverages Corp.Technical Analysis: - Support: 4.92; 5.47 - Resistance: 5.71; 5.96; 6.30 I would recommend a SL: 5.96 and a TP: 3.52 - MACD: Short - RSI: Short - Momentum: Short - OBV: Short Fundamental Analysis: Head Line: "CBD-Infused Beverages, Delayed Indefinitely" "It is unlawful under the FD&C Act to introduce food containing added CBD or THC into interstate commerce , or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived. This is a requirement that we apply across the board to food products that contain substances that are active ingredients in any drug.” FDA didn't changed its opinion after the Farm Bill at 20th December -> CBD infused products are still illegal Consequences: "The company will face significant delays and reduce guidance in 2019"
NShort
by UnknownUnicorn3863111
If you want to invest into cannabis? You might like Sunniva! The cannabis sector is like the dotcom or the tech boom that went from explosion to implosion. Now it starts to get interesting in the new market. The extreme speculative and euphoric time is over and now it begins the value pricing. I guess there will be one more leg down and then the blood is all over and real investing begins. Companies like Aurora, Canopy or Aphria had their times and other players will start to attract investors money. And in my opinion it is time to start looking at a company that is called Sunniva Inc SNNVF. They are close to finish phase 1 on their California Cannabis Campus and they already have a signed contract to deliver 45.000 kg of Cannabis to Canopy Growth in 2019. They just started selling in Cali and as you might know, this will be the biggest market for the medical and recreational products in the world. I took my first position in the 2.30s and planing to accumulate more when it dips into the 2.50 area, if this might ever happen again. But this will be a mega growth story cause they missed the whole ride in 2018. They had their IPO when the bubble was already so overextended and they just jumped up to around 16$ from 7.50$ within a few days and then started to fall like a rock. Also they are not listed on a major us exchange and that makes them a not much recognized player. This will be the biggest story to come in 2019 like Tilray had in 2018. Sunniva has only around 45 Million shares and that will cause a hell of a ride when people really start to realize what it is all about with this company. www.sunniva.com Just my opinion so make your own research And like always Mai the markets be with you
OTC:SNNVFLong
by derfreietrader
BTC-CANN CannabisCoin - Alt Coin Analysis - Point SystemAlt Coin Analysis - Points out of 10 Date : Since 2014 ( 8 / 10 ) Volume 24 H : 3 BTC ( 2 / 10 ) Available Markets* ( 1 / 10 ) Huge Risk Social Media Rate ( 3 / 10 ) Ranks ** - 870 ( 2 / 10 ) Website ( 1 / 10 ) Type Cannabis Coin Overall ( 2 /10 ) At 200 - 215 satoshi, Good Risk & Reward. The coin is on ALL TIME LOW level since 2014! If you dont think BTC found the bottom, dont touch this coin! Sell with the next pump, Dont hold it for a long time. * Considering top 10 crypto exchanges ** Top 100 coins on coin market cap get 10 points
CLong
by CryptoEngineering
$GCAN Patented Dosage System and Cannabis Dream Team of Execs$GCAN has now Landed The former CEO of a billion dollar multi-national Company, and a distinguished scientist along with 7 others: Aitan Zacharin - $GCAN's new CEO identified and hired executive talent to lead the commercialization strategy including the past President of SC Johnson Company and previous CEO of Champs and Footlocker Sports. He successfully led the company to raise over $10M in three over-subscribed rounds, as well as negotiated contracts with 26 world renowned athlete and celebrity brand ambassadors, which included top ranked pro golfer Tiger Woods. Mark Radom - $GCAN NEW Legal COUNSEL worked on Wall Street and in the City of London as a US securities and capital markets lawyer where he represented sovereigns, global investment banks and fortune 500 companies across a broad range of capital raising and corporate transactions. David Tavor - Chairman of the Board of Pharmedica and now the Managing Director of $GCAN pharmedica.co.il Dr. Hock Tan - GCAN's new Chairman of Scientific Advisory Board globenewswire.com Elisha Kalfa - Chief Operating Officer at North American Dental www.nadental.com Joe Kalfa - Founder - North American Dental with 50 employees world Wide with over 2800 Followers Dentist just like Doctors can write RX prescription and what will GCAN's Green C owner of a Exclusive World Wide License for an orally dissolved film containing Cannabis, do for GCAN. www.otcmarkets.com Does something like Johnson And Johnson Listerine Strips but infused with Cannabis come to mind? We all know how popular those Strips are. Johnson And Johnson buys out Listerine brand for 16.6 billion www.cosmeticsdesign.com Think about what GCAN with it's Canadian Cannabis Dream Team along with Our Exclusive World Wide License and Cannabis Oral products will do for GCAN the company and it's shareholders. Dentists just like Doctors can write RX prescription $GCAN RX products managed by a team with Dental distributors already in place.
OTC:GCANLong
by StockGuild
$ETII Update on CBD Pet Products and mentioned in NASDAQ ArticleThe common benefits of CBD in dogs Current research shows that there are several common CBD benefits for dogs, which are, 1) powerful painkiller (the ECS is involved in managing pain and CBD's pain killing properties are well documented}; 2) effective anticonvulsant (CBD helps control seizures, tremors, tics and spasms); 3) natural anti-inflammatory; 4) anxiety and stress reducer (anxiety in dogs often results in in barking, urination and defecation, chewing and aggression); 5) active antiemetic (reduces nausea and vomiting); and homeostasis promoter (proper functioning of the body). "Pet owners are committed to their pet's health well-being and are willing to spend money on pet health products, which make this a multi-billion dollar market, worldwide," said Karren. "We hope to introduce our CBD pet products in 2019 as we believe that our CBD pet products will be superior to those currently offered in this huge industry and will create another profitable channel for our CBD products." $ETII was also mentioned in a NASDAQ article released today with a few other top name CBD brands: www.nasdaq.com According to the American Pet Products Association (APPA), $69.51 billion was spent on pets in the U.S in 2017 and it’s estimated that number will grow to $72.13 billion for 2018. Canadians spend $6.6 billion a year on their pets according to recent numbers. Looking at how cannabis/CBD plays into the pet market, CTV reported, “In 2017, sales of cannabis products marketed for pets at medical and adult-use cannabis dispensaries was nearly $7 million in California, Colorado, Oregon and Washington, according to BDS Analytics. In Colorado, sales of pet products grew 49 per cent in 2017, versus growth across all product categories at 15 per cent, it said.” Canopy Animal Health, stated as the global leader in cannabinoid science for pets, is a division of Canopy Health, a wholly owned subsidiary of Canopy Growth Corporation ( TSX:WEED ), ( NYSE:CGC ). In August they announced that approval had been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol (“CBD”) to treat anxiety in certain animals. Continued: The research will be conducted by Canopy Animal Health, a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals. The approval comes in the form of a No Objection Letter for the use of a proprietary CBD enriched oil formulation, previously administered in preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD formulation will be produced by Canopy Growth in its GMP-certified production facility in Smiths Falls, Ontario. www.apnews.com Check out the company's website here for more information: www.envirotechnologiesinternational.com
OTC:ETIILong
by StockGuild
CO2 GRO Technical Analysis: 100% return over next 1-2 months Short term we are due for at least a small bounce since we finally have some signs of buying volume increasing. Note the bull volume spikes end of this week as well as back in June before the last uptrend started. Daily MACD is just about to cross which when combined with stochastics rising out of oversoold indicate a likely uptrend beginning. $0.15 was a major support and now is acting as significant resistance, a break above this level would 100% confirm the continuation of the megaphone chart pattern up to at least $0.30. Easy 100% return over next 1-2 months even without any major catalysts, but this company has first revenue coming any week now as well as new research/trials being completed monthly. 8 Million market cap and projected revenue stream for 2019 is $10 million.
TSXV:GROWLong
by Unlikely-Bite